www.fdanews.com/articles/197687-uk-authorizes-dexamethasone-as-covid-19-treatment
UK Authorizes Dexamethasone as COVID-19 Treatment
June 19, 2020
The UK has authorized the use of the corticosteroid dexamethasone to reduce the risk of death in COVID-19 patients requiring ventilation or oxygen.
The UK government cited preliminary results from Oxford University’s RECOVERY trial, which showed that dexamethasone reduced the risk of death in ventilated patients by one-third, and by one-fifth in patients on oxygen.
The government said it is securing a supply of the drug for the treatment of more than 200,000 COVID-19 patients.